Growing Prevalence of Urological Diseases to Provide Lucrative Opportunities for the Ureteral Stent Market

 

Ureteral Stent Market

A ureteral stent is a thin flexible tube inserted directly into the ureter in order to prevent or remedy obstruction of the urinary passage from the ureter. The length of these stents used for adult patient’s ranges between 30 and 24 inches. Additionally, different diameters or sizes of stents are available, to suit different ureter sizes. This allows treatment options to be tailored to the individual, as well as to the extent of obstruction.

Urinary stents are made of either metal silicone or plastic. They are placed directly into the bladder via the urethra valve. Ureteral stents can either be made percutaneously, via surgery or by means of an outpatient procedure. Depending on the type of ureter that is affected, the procedure can be either a single needle or multiple needles.

The growing prevalence of urological diseases around the globe is driving the growth of the ureteral stents market. Growth in the kidney transplant coupled with the technological advancement in the ureteral stents is again contributing to the growth of the market. According to the United States Renal Data System, nearly 750,000 patients per year in the United States and an estimated 2 million patients worldwide are affected by kidney failure. The need for donor kidneys in the United States is rising at 8% per year. African Americans are 3.5 times more likely to have kidney failure. Moreover, growing healthcare spending by key manufacturers is further anticipated to foster the growth of the ureteral stents market.

North America is projected to gain significant growth over the forecast period and this is attributed to the rapid adoption of advanced medical devices including ureteral stents in the region. Also, the manufacturer are introducing innovative products for improving the efficacy which is further projected to propel the growth of the market. For instance, in April 2019, Dornier MedTech (Dornier), a global urology company and a provider of kidney stone management, announced the launch of its new AXIS™ Single-Use Digital Flexible Ureteroscope (AXIS™) and Stone Management Products in the United States.

Key Developments:

1.     In October 2020, Allium Medical Solutions Ltd., which specializes in minimally invasive technologies announced that its urological stents received CE Mark for a new indication for treating urethral fistula after a successful trial.

2.     In November 2017, Fannin Innovation Studio has been awarded a $224,692 grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to develop and test a novel medical device for removing ureteral stents in children.

Comments

Post a Comment

Popular posts from this blog

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Image
  With billions of dollars in research and development costs, pharmaceutical companies around the world are always looking for new ways to address their production processes in a cost-effective manner. One way to achieve this is through outsourcing drug discovery and development services. This type of service refers to the collaboration between small and large biotech and biotechnology companies to conduct research and development activities aimed at finding better solutions to the company's core chemical concerns. Outsourcing of these drug discovery services has enabled established pharmaceutical and biotechnology companies to focus on the development of new products that can bring about significant therapeutic change and provide tangible advantages to the company's shareholders. Contract research organizations manage almost all aspects of drug discovery. Market Dynamics I ncreasing demand for outsourcing analytical testing and clinical trial services, growing R&D ex...
Read more

Otoscope Market Is Gaining Major Traction with Industry Leader Otonexus Medical Technologies Introducing Ultrasound Sensor, Which Aids Middle-Ear Infection Diagnosis

Image
  An otoscope or auricular ear picker is a simple health care tool that is used to inspect the outer ear. Many health care professionals utilize otoscopes to examine ear infections during routine check-ups and to also screen for serious ear disorders. An otoscope possibly provides a more detailed view of the external ear canal and/or ear drum or eardrum. Otoscope or also referred to as auriscope is mainly used to look into eyes. The demand for these medical devices has been on a rise in the recent past. This is typically due to the fact that there is a high burden of ENT-related diseases across the globe. As per the World Health Organization (WHO), by 2050, around 2.5 billion people are estimated to have some degree of hearing loss worldwide. Similarly, there is a heavy burden of sinusitis cases. As per the Sinusitis & Allergy Wellness Center, around 30 million adults in the U.S. are impacted with sinusitis annually. Such a high prevalence of ENT disorders has accelerated the d...
Read more

The Number of Cancer Survivors Is Projected To Increase to 22.2 Million By 2030 Fostering Oncology Drug Pipeline Analysis Market

Image
  North America is estimated to dominate the global oncology drug pipeline analysis market in the near future and this is attributed to the high prevalence of cancer and increasing launch of various novel drugs with improved efficacy. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. The oncology field is experiencing significant growth and this is attributed to the increasing development of various novel therapies for the treatment of cancer. For instance, in February 2021, Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with a 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its the novel, next-generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood c...
Read more